189 related articles for article (PubMed ID: 38354780)
21. Inactivation of the Cullin (CUL)-RING E3 ligase by the NEDD8-activating enzyme inhibitor MLN4924 triggers protective autophagy in cancer cells.
Luo Z; Pan Y; Jeong LS; Liu J; Jia L
Autophagy; 2012 Nov; 8(11):1677-9. PubMed ID: 22874562
[TBL] [Abstract][Full Text] [Related]
22. Structure of CRL7
Hopf LVM; Baek K; Klügel M; von Gronau S; Xiong Y; Schulman BA
Nat Struct Mol Biol; 2022 Sep; 29(9):854-862. PubMed ID: 35982156
[TBL] [Abstract][Full Text] [Related]
23. SENP8 limits aberrant neddylation of NEDD8 pathway components to promote cullin-RING ubiquitin ligase function.
Coleman KE; Békés M; Chapman JR; Crist SB; Jones MJ; Ueberheide BM; Huang TT
Elife; 2017 May; 6():. PubMed ID: 28475037
[TBL] [Abstract][Full Text] [Related]
24. Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation.
Duda DM; Borg LA; Scott DC; Hunt HW; Hammel M; Schulman BA
Cell; 2008 Sep; 134(6):995-1006. PubMed ID: 18805092
[TBL] [Abstract][Full Text] [Related]
25. NEDD8 and ubiquitin ligation by cullin-RING E3 ligases.
Baek K; Scott DC; Schulman BA
Curr Opin Struct Biol; 2021 Apr; 67():101-109. PubMed ID: 33160249
[TBL] [Abstract][Full Text] [Related]
26. [Targeting Cullin-RING E3 ligases for anti-cancer therapy: efforts on drug discovery].
Yu Q; Xiong X; Sun Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(1):1-19. PubMed ID: 32621419
[TBL] [Abstract][Full Text] [Related]
27. Nedd8-Activating Enzyme Is a Druggable Host Dependency Factor of Human and Mouse Cytomegalovirus.
Flores-Martínez YA; Le-Trilling VTK; Trilling M
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452475
[TBL] [Abstract][Full Text] [Related]
28. Two Distinct Types of E3 Ligases Work in Unison to Regulate Substrate Ubiquitylation.
Scott DC; Rhee DY; Duda DM; Kelsall IR; Olszewski JL; Paulo JA; de Jong A; Ovaa H; Alpi AF; Harper JW; Schulman BA
Cell; 2016 Aug; 166(5):1198-1214.e24. PubMed ID: 27565346
[TBL] [Abstract][Full Text] [Related]
29. TRIAD1 and HHARI bind to and are activated by distinct neddylated Cullin-RING ligase complexes.
Kelsall IR; Duda DM; Olszewski JL; Hofmann K; Knebel A; Langevin F; Wood N; Wightman M; Schulman BA; Alpi AF
EMBO J; 2013 Oct; 32(21):2848-60. PubMed ID: 24076655
[TBL] [Abstract][Full Text] [Related]
30. Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation.
Saha A; Deshaies RJ
Mol Cell; 2008 Oct; 32(1):21-31. PubMed ID: 18851830
[TBL] [Abstract][Full Text] [Related]
31. Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy.
Zhao Y; Morgan MA; Sun Y
Antioxid Redox Signal; 2014 Dec; 21(17):2383-400. PubMed ID: 24410571
[TBL] [Abstract][Full Text] [Related]
32. Gln40 deamidation blocks structural reconfiguration and activation of SCF ubiquitin ligase complex by Nedd8.
Yu C; Mao H; Novitsky EJ; Tang X; Rychnovsky SD; Zheng N; Huang L
Nat Commun; 2015 Dec; 6():10053. PubMed ID: 26632597
[TBL] [Abstract][Full Text] [Related]
33. Nedd8-modification of Cul1 is promoted by Roc1 as a Nedd8-E3 ligase and regulates its stability.
Morimoto M; Nishida T; Nagayama Y; Yasuda H
Biochem Biophys Res Commun; 2003 Feb; 301(2):392-8. PubMed ID: 12565873
[TBL] [Abstract][Full Text] [Related]
34. Activity-based profiling of cullin-RING E3 networks by conformation-specific probes.
Henneberg LT; Singh J; Duda DM; Baek K; Yanishevski D; Murray PJ; Mann M; Sidhu SS; Schulman BA
Nat Chem Biol; 2023 Dec; 19(12):1513-1523. PubMed ID: 37653169
[TBL] [Abstract][Full Text] [Related]
35. Rotavirus NSP1 Associates with Components of the Cullin RING Ligase Family of E3 Ubiquitin Ligases.
Lutz LM; Pace CR; Arnold MM
J Virol; 2016 Jul; 90(13):6036-48. PubMed ID: 27099313
[TBL] [Abstract][Full Text] [Related]
36. Targeting Protein Neddylation to Inactivate Cullin-RING Ligases by Gossypol: A Lucky Hit or a New Start?
Yu Q; Sun Y
Drug Des Devel Ther; 2021; 15():1-8. PubMed ID: 33442232
[TBL] [Abstract][Full Text] [Related]
37. Cullin-RING Ubiquitin Ligase Regulatory Circuits: A Quarter Century Beyond the F-Box Hypothesis.
Harper JW; Schulman BA
Annu Rev Biochem; 2021 Jun; 90():403-429. PubMed ID: 33823649
[TBL] [Abstract][Full Text] [Related]
38. Protection of cullin-RING E3 ligases by CSN-UBP12.
Wu JT; Chan YR; Chien CT
Trends Cell Biol; 2006 Jul; 16(7):362-9. PubMed ID: 16762551
[TBL] [Abstract][Full Text] [Related]
39. Structural basis for Cullins and RING component inhibition: Targeting E3 ubiquitin pathway conductors for cancer therapeutics.
Shafique S; Ali W; Kanwal S; Rashid S
Int J Biol Macromol; 2018 Jan; 106():532-543. PubMed ID: 28802844
[TBL] [Abstract][Full Text] [Related]
40. Assembly and Regulation of CRL Ubiquitin Ligases.
Wang K; Deshaies RJ; Liu X
Adv Exp Med Biol; 2020; 1217():33-46. PubMed ID: 31898220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
